Creative Medical Technology Holdings, Inc. (CELZ)
(Real Time Quote from BATS)
$3.53 USD
+0.02 (0.57%)
Updated Aug 7, 2025 10:28 AM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Creative Medical Technology Holdings, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CELZ 3.53 +0.02(0.57%)
Will CELZ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CELZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CELZ
New Strong Sell Stocks for July 31st
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock?
CELZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year?
Other News for CELZ
Creative Medical (CELZ) Advances with Patent Approval for Diabetes Treatment | CELZ Stock News
Creative Medical receives notice of allowance for prevention, treatment of T1D
Creative Medical (CELZ) Achieves Milestone with New US Patent Approval | CELZ Stock News